文献速递慢性肾脏病遗传性与小管间质肾病

慢性肾脏病中的骨、炎症与骨髓微环境:我们已知什么?

Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know?
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

本文综述了骨作为内分泌器官的新认识,探讨骨激素(骨钙素、FGF23、硬骨素)和碱性磷酸酶与心血管结局的关联,以及骨-炎症、骨-血管轴和骨髓微环境的概念。作者提出肾性骨营养不良可能为骨髓微环境功能障碍的原因,强调整合骨与骨髓微环境的视角对理解CKD-MBD及其心血管负担的必要性。

要点

  • 骨不再仅视为二价离子库,而是具有骨外效应的内分泌器官。
  • 骨激素和碱性磷酸酶可能解释骨质疏松和肾性骨营养不良的心血管风险。
  • 肾性骨营养不良未来可能被识别为骨髓微环境功能障碍的原因。

核心结论

  • 骨应被视为内分泌器官,其激素和酶与心血管结局相关。
  • 骨髓微环境功能障碍可能是糖尿病和未来肾性骨营养不良的新机制。
  • 整合骨与骨髓微环境的视角对理解CKD-MBD及其心血管负担是必要的。

研究设计与样本

  • 本文为叙述性综述,检索范围未在摘要中报告。

主要发现

  • 骨激素(骨钙素、FGF23、硬骨素)和碱性磷酸酶可能解释骨质疏松和肾性骨营养不良与心血管不良结局的关联。
  • 慢性炎症状态(从类风湿关节炎到衰老)与骨丢失和骨质疏松相关。
  • 骨-血管轴概念可能解释骨代谢与动脉粥样硬化、动脉硬化等血管壁疾病的关系。
  • 骨髓微环境是干细胞相互作用的功能单位,其功能障碍在糖尿病中称为糖尿病 mobilopathy。

临床怎么用

  • 临床应关注骨激素和碱性磷酸酶作为心血管风险标志物的潜在价值。
  • 对复杂疾病患者需考虑骨与骨髓微环境的整合视角。

局限性

  • 本文为综述,未报告系统检索策略和纳入标准。
  • 骨髓微环境功能障碍在肾性骨营养不良中的作用为作者推测,尚未证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Recent improvements in our understanding of physiology have altered the way in which bone is perceived: no longer is it considered as simply the repository of divalent ions, but rather as a sophisticated endocrine organ with potential extraskeletal effects. Indeed, a number of pathologic conditions involving bone in different ways can now be reconsidered from a bone-centred perspective. For example, in metabolic bone diseases like osteoporosis (OP) and renal osteodystrophy (ROD), the association with a worse cardiovascular outcome can be tentatively explained by the possible derangements of three recently discovered bone hormones (osteocalcin, fibroblast growth factor 23 and sclerostin) and a bone-specific enzyme (alkaline phosphatase). Further, in recent years the close link between bone and inflammation has been better appreciated and a wide range of chronic inflammatory states (from rheumatoid arthritis to ageing) are being explored to discover the biochemical changes that ultimately lead to bone loss and OP. Also, it has been acknowledged that the concept of the bone-vascular axis may explain, for example, the relationship between bone metabolism and vessel wall diseases like atherosclerosis and arteriosclerosis, with potential involvement of a number of cytokines and metabolic pathways. A very important discovery in bone physiology is the bone marrow (BM) niche, the functional unit where stem cells interact, exchanging signals that impact on their fate as bone-forming cells or immune-competent haematopoietic elements. This new element of bone physiology has been recognized to be dysfunctional in diabetes (so-called diabetic mobilopathy), with possible clinical implications. In our opinion, ROD, the metabolic bone disease of renal patients, will in the future probably be identified as a cause of BM niche dysfunction. An integrated view of bone, which includes the BM niche, now seems necessary in order to understand the complex clinical entity of chronic kidney disease-mineral and bone disorders and its cardiovascular burden. Bone is thus becoming a recurrently considered paradigm for different inter-organ communications that needs to be considered in patients with complex diseases.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Mazzaferro S, Cianciolo G, De Pascalis A, et al. Bone, inflammation and the bone marrow niche in chronic kidney disease: what do we know? Nephrol Dial Transplant. 2018. PMID: 29733407. doi:10.1093/ndt/gfy115

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。